Baillie Gifford & Co
ATEX icon

Baillie Gifford & Co’s Anterix ATEX Stock Holding History

Baillie Gifford & Co’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-162
Closed -$5.35K – 306
2023
Q1 		$5.35K Hold
162
– – ﹤0.01% 414
2022
Q4 		$5.21K Hold
162
– – ﹤0.01% 446
2022
Q3 		$6K Hold
162
– – ﹤0.01% 433
2022
Q2 		$7K Hold
162
– – ﹤0.01% 434
2022
Q1 		$9K Hold
162
– – ﹤0.01% 440
2021
Q4 		$10K Hold
162
– – ﹤0.01% 446
2021
Q3 		$10K Hold
162
– – ﹤0.01% 445
2021
Q2 		$10K Hold
162
– – ﹤0.01% 433
2021
Q1 		$8K Hold
162
– – ﹤0.01% 415
2020
Q4 		$6K Buy
+162
New +$5.34K ﹤0.01% 409

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JCP
Jennifer C. Price $75.5M AUM 6.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Baillie Gifford & Co's ATEX Position: Q2 2023 in Review

Baillie Gifford & Co sold out of Anterix (ATEX) in Q2 2023, closing a stake of 162 shares — an estimated $5.35K sold.

Baillie Gifford & Co first reported a position in ATEX in Q4 2020 and held it in 10 quarters. The position peaked at $10K in Q4 2021. 95 funds tracked by Wall St. Rank hold ATEX as of Q2 2023.

  • Baillie Gifford & Co reported no remaining Anterix position as of Q2 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 162 Anterix shares in Q2 2023, an estimated $5.35K.
  • Baillie Gifford & Co first reported a position in Anterix in Q4 2020 and held it in 10 quarters.
  • Baillie Gifford & Co's Anterix position peaked at $10K in Q4 2021.
  • 95 funds tracked by Wall St. Rank held Anterix as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.